Literature DB >> 21538727

Constitutive activation of nuclear factor-E2-related factor 2 induces biotransformation enzyme and transporter expression in livers of mice with hepatocyte-specific deletion of Kelch-like ECH-associated protein 1.

Qiuqiong Cheng1, Keiko Taguchi, Lauren M Aleksunes, José E Manautou, Nathan J Cherrington, Masayuki Yamamoto, Angela L Slitt.   

Abstract

Chemicals that activate nuclear factor-E2-related factor 2 (Nrf2) often increase multidrug-resistance-associated protein (Mrp) expression in liver. Hepatocyte-specific deletion of Kelch-like ECH-associated protein 1 (Keap1) activates Nrf2. Use of hepatocyte-specific Keap1 deletion represents a nonpharmacological method to determine whether constitutive Nrf2 activation upregulates liver transporter expression in vivo. The mRNA, protein expression, and localization of several biotransformation and transporters were determined in livers of wild-type and hepatocyte-specific Keap1-null mice. Sulfotransferase 2a1/2, NADP(H):quinone oxidoreductase 1, cytochrome P450 2b10, 3a11, and glutamate-cysteine ligase catalytic subunit expression were increased in livers of Keap1-null mice. Organic anion-transporting polypeptide 1a1 expression was nearly abolished, as compared to that detected in livers of wild-type mice. By contrast, Mrp 1-5 mRNA and protein levels were increased in Keap1-null mouse livers, with Mrp4 expression being more than 15-fold higher than wild types. In summary, Nrf2 has a significant role in affecting Oatp and Mrp expressions.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538727      PMCID: PMC3710738          DOI: 10.1002/jbt.20392

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  33 in total

1.  Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression.

Authors:  Michael McMahon; Ken Itoh; Masayuki Yamamoto; John D Hayes
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

2.  Detection of chemical-induced differential expression of rat hepatic cytochrome P450 mRNA transcripts using branched DNA signal amplification technology.

Authors:  D P Hartley; C D Klaassen
Journal:  Drug Metab Dispos       Date:  2000-05       Impact factor: 3.922

Review 3.  Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.

Authors:  Nicole F Villeneuve; Alexandria Lau; Donna D Zhang
Journal:  Antioxid Redox Signal       Date:  2010-08-14       Impact factor: 8.401

4.  Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione.

Authors:  M K Kwak; K Itoh; M Yamamoto; T R Sutter; T W Kensler
Journal:  Mol Med       Date:  2001-02       Impact factor: 6.354

5.  Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor.

Authors:  J M Pascussi; L Drocourt; S Gerbal-Chaloin; J M Fabre; P Maurel; M J Vilarem
Journal:  Eur J Biochem       Date:  2001-12

6.  Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts.

Authors:  Asako Hayashi; Hiroshi Suzuki; Ken Itoh; Masayuki Yamamoto; Yuichi Sugiyama
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

7.  Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor.

Authors:  Nathan J Cherrington; Angela L Slitt; Jonathan M Maher; Xiao-Xue Zhang; Jun Zhang; Wendong Huang; Yu-Jui Yvonne Wan; David D Moore; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2003-11       Impact factor: 3.922

8.  Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence.

Authors:  Paul Nioi; Michael McMahon; Ken Itoh; Masayuki Yamamoto; John D Hayes
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

9.  Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles.

Authors:  Ken Itoh; Nobunao Wakabayashi; Yasutake Katoh; Tetsuro Ishii; Tania O'Connor; Masayuki Yamamoto
Journal:  Genes Cells       Date:  2003-04       Impact factor: 1.891

10.  Rat multidrug resistance protein 4 (Mrp4, Abcc4): molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility.

Authors:  Chuan Chen; Curtis D Klaassen
Journal:  Biochem Biophys Res Commun       Date:  2004-04-23       Impact factor: 3.575

View more
  3 in total

Review 1.  Nrf2: a potential target for new therapeutics in liver disease.

Authors:  A M Bataille; J E Manautou
Journal:  Clin Pharmacol Ther       Date:  2012-08-08       Impact factor: 6.875

2.  Transcriptional Regulation of Solute Carrier (SLC) Drug Transporters.

Authors:  Shiwei Zhou; Yan Shu
Journal:  Drug Metab Dispos       Date:  2022-05-29       Impact factor: 3.579

3.  Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver.

Authors:  Kai Connie Wu; Julia Yue Cui; Curtis D Klaassen
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.